ABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Gastritis/drug therapy , Emphysema/drug therapy , Anti-Bacterial Agents/therapeutic use , Gastritis/complications , Gastrointestinal Hemorrhage/etiologySubject(s)
Emphysema/drug therapy , Gastritis/drug therapy , Metronidazole/therapeutic use , Penicillanic Acid/analogs & derivatives , Aged , Analgesics/therapeutic use , Anti-Bacterial Agents/therapeutic use , Diabetes Mellitus, Type 2/complications , Drug Therapy, Combination , Early Diagnosis , Emergencies , Emphysema/diagnostic imaging , Female , Fluid Therapy , Gastritis/diagnostic imaging , Gastrointestinal Hemorrhage/etiology , Humans , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Proton Pump Inhibitors/therapeutic use , Tomography, X-Ray ComputedABSTRACT
There is a consensus that nutritional support, which must be provided to patients in intensive care, influences their clinical outcome. Malnutrition is associated in critically ill patients with impaired immune function and impaired ventilator drive, leading to prolonged ventilator dependence and increased infectious morbidity and mortality. Enteral nutrition is an active therapy that attenuates the metabolic response of the organism to stress and favorably modulates the immune system. It is less expensive than parenteral nutrition and is preferred in most cases because of less severe complications and better patient outcomes, including infections, and hospital cost and length of stay. The aim of this work was to perform a review of the use of enteral nutrition in critically ill patients.
